452 related articles for article (PubMed ID: 16842268)
1. Prospects for recombinant vaccines against Babesia bovis and related parasites.
Brown WC; Norimine J; Goff WL; Suarez CE; McElwain TF
Parasite Immunol; 2006 Jul; 28(7):315-27. PubMed ID: 16842268
[TBL] [Abstract][Full Text] [Related]
2. Immune control of Babesia bovis infection.
Brown WC; Norimine J; Knowles DP; Goff WL
Vet Parasitol; 2006 May; 138(1-2):75-87. PubMed ID: 16510249
[TBL] [Abstract][Full Text] [Related]
3. Potential for recombinant Babesia bovis antigens to protect against a highly virulent isolate.
Hope M; Riding G; Menzies M; Colditz I; Reverter A; Willadsen P
Parasite Immunol; 2005 Dec; 27(12):439-45. PubMed ID: 16255742
[TBL] [Abstract][Full Text] [Related]
4. Identification of common antigens in Babesia bovis, B. bigemina, and B. divergens.
Figueroa JV; Precigout E; Carcy B; Gorenflot A
Ann N Y Acad Sci; 2006 Oct; 1081():382-96. PubMed ID: 17135542
[TBL] [Abstract][Full Text] [Related]
5. Serological responses to Babesia bovis vaccination in cattle previously infected with Babesia bigemina.
Combrink MP; Troskie PC; Du Plessis F; Latif AA
Vet Parasitol; 2010 May; 170(1-2):30-6. PubMed ID: 20207488
[TBL] [Abstract][Full Text] [Related]
6. Vaccination of cattle against B. bovis infection with live attenuated parasites and non-viable immunogens.
Fish L; Leibovich B; Krigel Y; McElwain T; Shkap V
Vaccine; 2008 Dec; 26 Suppl 6():G29-33. PubMed ID: 19178890
[TBL] [Abstract][Full Text] [Related]
7. Efficiency of a recombinant MSA-2c-based ELISA to establish the persistence of antibodies in cattle vaccinated with Babesia bovis.
Bono MF; Mangold AJ; Baravalle ME; Valentini BS; Thompson CS; Wilkowsky SE; Echaide IE; Farber MD; Torioni de Echaide SM
Vet Parasitol; 2008 Nov; 157(3-4):203-10. PubMed ID: 18783887
[TBL] [Abstract][Full Text] [Related]
8. Designing blood-stage vaccines against Babesia bovis and B. bigemina.
Brown WC; Palmer GH
Parasitol Today; 1999 Jul; 15(7):275-81. PubMed ID: 10377530
[TBL] [Abstract][Full Text] [Related]
9. Molecular approaches to elucidating innate and acquired immune responses to Babesia bovis, a protozoan parasite that causes persistent infection.
Brown WC
Vet Parasitol; 2001 Nov; 101(3-4):233-48. PubMed ID: 11707299
[TBL] [Abstract][Full Text] [Related]
10. Search for Babesia bovis vaccine candidates.
Florin-Christensen M; Schnittger L; Dominguez M; Mesplet M; Rodríguez A; Ferreri L; Asenzo G; Wilkowsky S; Farber M; Echaide I; Suarez C
Parassitologia; 2007 May; 49 Suppl 1():9-12. PubMed ID: 17691600
[TBL] [Abstract][Full Text] [Related]
11. Field challenge of cattle vaccinated with a combined Babesia bovis and Babesia bigemina frozen immunogen.
Alvarez JA; Ramos JA; Rojas EE; Mosqueda JJ; Vega CA; Olvera AM; Figueroa JV; Cantó GJ
Ann N Y Acad Sci; 2004 Oct; 1026():277-83. PubMed ID: 15604506
[TBL] [Abstract][Full Text] [Related]
12. Vaccination of older Bos taurus bulls against bovine babesiosis.
Shkap V; Leibovitz B; Krigel Y; Hammerschlag J; Marcovics A; Fish L; Molad T; Savitsky I; Mazuz M
Vet Parasitol; 2005 May; 129(3-4):235-42. PubMed ID: 15845278
[TBL] [Abstract][Full Text] [Related]
13. Babesia bovis: characterization of the T helper cell response against the 42-kDa merozoite surface antigen (MSA-1) in cattle.
Brown WC; Palmer GH; McElwain TF; Hines SA; Dobbelaere DA
Exp Parasitol; 1993 Aug; 77(1):97-110. PubMed ID: 8344411
[TBL] [Abstract][Full Text] [Related]
14. Advances in the development of molecular tools for the control of bovine babesiosis in Mexico.
Mosqueda J; Figueroa JV; Alvarez A; Bautista R; Falcon A; Ramos A; Canto G; Vega CA
Parassitologia; 2007 May; 49 Suppl 1():19-22. PubMed ID: 17691602
[TBL] [Abstract][Full Text] [Related]
15. Comparison of different direct diagnostic methods to identify Babesia bovis and Babesia bigemina in animals vaccinated with live attenuated parasites.
Costa-Júnior LM; Rabelo EM; Martins Filho OA; Ribeiro MF
Vet Parasitol; 2006 Jun; 139(1-3):231-6. PubMed ID: 16580136
[TBL] [Abstract][Full Text] [Related]
16. Comparison of cattle responses to mono-specific or combined inoculations with Babesia bigemina and Babesia bovis vaccine strains.
Viseras J; Lugaresi CI; Volpogni MM; Guglielmone AA
Parasite; 1999 Mar; 6(1):67-9. PubMed ID: 10229940
[TBL] [Abstract][Full Text] [Related]
17. Antigenic variation as an exploitable weakness of babesial parasites.
Allred DR; Al-Khedery B
Vet Parasitol; 2006 May; 138(1-2):50-60. PubMed ID: 16517078
[TBL] [Abstract][Full Text] [Related]
18. Emerging perspectives in the research of bovine babesiosis and anaplasmosis.
Suarez CE; Noh S
Vet Parasitol; 2011 Aug; 180(1-2):109-25. PubMed ID: 21684084
[TBL] [Abstract][Full Text] [Related]
19. Artemisone inhibits in vitro and in vivo propagation of Babesia bovis and B. bigemina parasites.
Mazuz ML; Golenser J; Fish L; Haynes RK; Wollkomirsky R; Leibovich B; Shkap V
Exp Parasitol; 2013 Dec; 135(4):690-4. PubMed ID: 24184077
[TBL] [Abstract][Full Text] [Related]
20. Hydrophobic moeties in recombinant proteins are crucial to generate efficient saponin-based vaccine against Apicomplexan Babesia divergens.
Delbecq S; Hadj-Kaddour K; Randazzo S; Kleuskens J; Schetters T; Gorenflot A; Précigout E
Vaccine; 2006 Jan; 24(5):613-21. PubMed ID: 16199111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
